Log In
BCIQ
Print this Print this
 

LAIV H5N2/A/Len/17 (SCH 900795)

  Manage Alerts
Collapse Summary General Information
Company BioDiem Ltd.
DescriptionVaccine based on a genetic reassortment of an attenuated H2N2 strain and a non-pathogenic avian H5 virus
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsPrevent pandemic influenza; Vaccinate against influenza virus
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today